You have Javascript disabled. Some elements of this page may not work as expected.
Hi, we've made some changes
Mylan is a leading generic and specialty pharmaceutical company whose products are used in areas including cardiovascular, central nervous system, dermatology and gastrointestinal. The Pennsylvania-based business was set up in 1961.
Div Yield
0.7%
0.7%
Div Cover
-74.8
6.0
Op Mrgn
-45.4%
4.1%
ROCE
-76.9%
P/E
n/a
24.0
PEG
n/a
n/a
Pr/Revenue
1.2
0.8
Pr/Book
1.0
Revenue
79.4%
105.1%
PBT
n/a
n/a
EPS
n/a
n/a
DPS
-66.8%
3.0%
31-Mar-04
1,374.62
512.61
124.00¢
37.0
1.4
+26%
10.00¢
0.2%
31-Mar-05
1,253.37
312.25
76.00¢
47.9
n/a
-39%
12.00¢
0.3%
31-Mar-06
1,257.16
274.61
80.00¢
29.2
5.8
+5%
24.00¢
1.0%
31-Mar-07
1,611.82
425.51
101.00¢
20.9
0.8
+26%
24.00¢
1.1%
31-Dec-07
2,178.76
(1,081.06)
(595.95)¢
n/a
n/a
n/a
7.96¢
0.6%
31-Dec-08
4,469.21 185.09
49.45¢
24.0
n/a
n/a
8.20¢
0.7%
31-Dec-09
5,140.40 567.55
99.32¢
11.9
0.1
+101%
2.00¢
0.2%
Currency
US Dollars
Share Price
$11.85
Change Today
-$0.30
52 Week High
$18.17
52 Week Low
$10.33
Volume
3,669,731
Shares Issued
304.38m
Market Cap
$3,606.85m
Beta
0.53
RiskGrade
170
Strong Buy
8
Buy
2
Neutral
3
Sell
0
Strong Sell
0
Total
13
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.
13:05
815 @ $11.85
13:05
60 @ $11.85
12:59
1 @ $11.86
12:59
2 @ $11.87
12:59
1 @ $11.84
Please wait, loading...